Free Trial

Equities are finding a delayed bid, post...>

EQUITIES: Equities are finding a delayed bid, post the US PPI data. 
But the re-emergence in buying interest is following Gilead announcing data on
the Remdesivir treatment. 
-Bloomberg reported that the research found:
-"74.4% of remdesivir-treated patients recovered by Day 14 versus 59%. While
Mortality rate fell to 7.6% vs 12.5% for patient not taking the treatment."

To read the full story

Why Subscribe to


MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.